Regis Kelly, executive director of University of California’s QB3 is retiring after more than 50 years with the institution.

Alastair Hick spent, up until now senior director of Monash Innovation, will serve as the university’s inaugural chief commercialisation officer.

IP Group has established Kiko Ventures to build out its existing $215m cleantech portfolio and will invest $245m over the next five years.

Just one week after investing in University of Melbourne’s Genesis Pre-Seed Fund, Breakthrough Victoria has unveiled plans to create funds with more local universities.

Osage University Partners has added MicroTransponder to a small but mightly portfolio of medical device companies.

Ascenion and Goethe University Frankfurt are among the initiators of Carma Fund I, which will help start up and fund early life science projects.

Chalmers spinout Elypta is working on a metabolism-based liquid biopsy for early cancer detection that it hopes will catch any type of the disease.

The embattled commercialisation firm reduced losses by nearly $40m but now has only one board member left in interim chairman Bruce Failing.

Tin Alley Ventures and Genesis Pre-Seed Fund will have a total of nearly $81m at their disposal to invest in University of Melbourne’s innovations.